Literature DB >> 9008299

State of aggregation of recombinant hirudin in solution under physiological conditions.

T W Thannhauser1, H A Scheraga.   

Abstract

The state of aggregation of recombinant desulfatohirudin (r-HV1) in solution under physiological conditions (pH 7.5, 0.15 N NaCl) was investigated by sedimentation equilibrium. The weight-average molecular weight MW determined by sedimentation equilibrium was found to be 6914 +/- 76 Da compared to 6964 Da expected from the amino acid sequence. The MZ/MW ratio was found to be 1.03, which demonstrates that under the conditions studied hirudin exists in solution as a monomer. This result is in agreement with the relative molecular weight (M,) of recombinant hirudin variant 3 reported by Otto and Seckler [(1991), Eur. J. Biochem. 202, 67-73], who also used equilibrium ultracentrifugation, but not with the molecular weight estimated from gel permeation chromatography of natural hirudin (51,300 Da) [Konno et al. (1988), Arch. Biochem. Biophys. 267, 158-166]. Knowledge of the state of aggregation is essential for understanding the mechanism of interaction of thrombin and hirudin under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008299     DOI: 10.1007/bf01887149

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  14 in total

1.  Kinetic studies of the regeneration of recombinant hirudin variant 1 with oxidized and reduced dithiothreitol.

Authors:  T W Thannhauser; D M Rothwarf; H A Scheraga
Journal:  Biochemistry       Date:  1997-02-25       Impact factor: 3.162

2.  Kinetics of the inhibition of thrombin by hirudin.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochemistry       Date:  1986-08-12       Impact factor: 3.162

3.  Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin.

Authors:  S Konno; J W Fenton; G B Villanueva
Journal:  Arch Biochem Biophys       Date:  1988-11-15       Impact factor: 4.013

4.  Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin.

Authors:  P J Braun; S Dennis; J Hofsteenge; S R Stone
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

5.  [Study of certain physicochemical constants of hirudin].

Authors:  C Tertrin; P De la Llosa; M Jutisz
Journal:  Biochim Biophys Acta       Date:  1966-08-24

6.  The disulfide folding pathway of hirudin elucidated by stop/go folding experiments.

Authors:  B Chatrenet; J Y Chang
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

7.  Characterization, stability and refolding of recombinant hirudin.

Authors:  A Otto; R Seckler
Journal:  Eur J Biochem       Date:  1991-11-15

8.  Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis.

Authors:  R P Harvey; E Degryse; L Stefani; F Schamber; J P Cazenave; M Courtney; P Tolstoshev; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  The folding of hirudin adopts a mechanism of trial and error.

Authors:  B Chatrenet; J Y Chang
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

10.  Identification of productive folding intermediates which account for the flow of protein folding pathway.

Authors:  J Y Chang
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.